Cargando…
Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S)
We report the clinical features of a patient with hereditary transthyretin (ATTR) amyloidosis associated with a novel mutation (Y114S, p.Y134S). A 65-year-old Japanese man was admitted to our hospital after a 3-year history of progressive dyspnea on exertion. Five years previously, he presented dyse...
Autores principales: | Nakase, Taku, Yamashita, Taro, Matsuo, Yoshimasa, Nomura, Toshiya, Sasada, Keiko, Masuda, Teruaki, Misumi, Yohei, Takamatsu, Kotaro, Oda, Seitaro, Furukawa, Yutaro, Obayashi, Konen, Matsui, Hirotaka, Ando, Yukio, Ueda, Mitsuharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794161/ https://www.ncbi.nlm.nih.gov/pubmed/31178489 http://dx.doi.org/10.2169/internalmedicine.2456-18 |
Ejemplares similares
-
New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis
por: Nomura, Toshiya, et al.
Publicado: (2019) -
Glavonoid, a possible supplement for prevention of ATTR amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2021) -
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
por: Brito, Dulce, et al.
Publicado: (2023) -
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021) -
Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2022)